BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34487753)

  • 1. Computational modeling of aberrant electrical activity following remuscularization with intramyocardially injected pluripotent stem cell-derived cardiomyocytes.
    Yu JK; Liang JA; Weinberg SH; Trayanova NA
    J Mol Cell Cardiol; 2022 Jan; 162():97-109. PubMed ID: 34487753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of arrhythmia mechanism and burden of the infarcted ventricles following remuscularization with pluripotent stem cell-derived cardiomyocyte patches using patient-derived models.
    Yu JK; Liang JA; Franceschi WH; Huang Q; Pashakhanloo F; Sung E; Boyle PM; Trayanova NA
    Cardiovasc Res; 2022 Mar; 118(5):1247-1261. PubMed ID: 33881518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pluripotent Stem Cell-Derived Cardiomyocyte Transplantation for Heart Disease Treatment.
    Kadota S; Shiba Y
    Curr Cardiol Rep; 2019 Jun; 21(8):73. PubMed ID: 31228011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart regeneration using pluripotent stem cells.
    Kadota S; Tanaka Y; Shiba Y
    J Cardiol; 2020 Nov; 76(5):459-463. PubMed ID: 32690435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graft-host coupling changes can lead to engraftment arrhythmia: a computational study.
    Gibbs CE; Marchianó S; Zhang K; Yang X; Murry CE; Boyle PM
    J Physiol; 2023 Jul; 601(13):2733-2749. PubMed ID: 37014103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene editing to prevent ventricular arrhythmias associated with cardiomyocyte cell therapy.
    Marchiano S; Nakamura K; Reinecke H; Neidig L; Lai M; Kadota S; Perbellini F; Yang X; Klaiman JM; Blakely LP; Karbassi E; Fields PA; Fenix AM; Beussman KM; Jayabalu A; Kalucki FA; Potter JC; Futakuchi-Tsuchida A; Weber GJ; Dupras S; Tsuchida H; Pabon L; Wang L; Knollmann BC; Kattman S; Thies RS; Sniadecki N; MacLellan WR; Bertero A; Murry CE
    Cell Stem Cell; 2023 Apr; 30(4):396-414.e9. PubMed ID: 37028405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac Cell Therapy with Pluripotent Stem Cell-Derived Cardiomyocytes: What Has Been Done and What Remains to Do?
    Selvakumar D; Reyes L; Chong JJH
    Curr Cardiol Rep; 2022 May; 24(5):445-461. PubMed ID: 35275365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.
    Zhu W; Zhao M; Mattapally S; Chen S; Zhang J
    Circ Res; 2018 Jan; 122(1):88-96. PubMed ID: 29018036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal Transplantation Confers Maturation of PSC-Derived Cardiomyocytes Conducive to Modeling Cardiomyopathy.
    Cho GS; Lee DI; Tampakakis E; Murphy S; Andersen P; Uosaki H; Chelko S; Chakir K; Hong I; Seo K; Chen HV; Chen X; Basso C; Houser SR; Tomaselli GF; O'Rourke B; Judge DP; Kass DA; Kwon C
    Cell Rep; 2017 Jan; 18(2):571-582. PubMed ID: 28076798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracoronary transplantation of pluripotent stem cell-derived cardiomyocytes: Inefficient procedure for cardiac regeneration.
    Kobayashi H; Tohyama S; Kanazawa H; Ichimura H; Chino S; Tanaka Y; Suzuki Y; Zhao J; Shiba N; Kadota S; Narita K; Naito T; Seto T; Kuwahara K; Shiba Y; Fukuda K
    J Mol Cell Cardiol; 2023 Jan; 174():77-87. PubMed ID: 36403760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates.
    Liu YW; Chen B; Yang X; Fugate JA; Kalucki FA; Futakuchi-Tsuchida A; Couture L; Vogel KW; Astley CA; Baldessari A; Ogle J; Don CW; Steinberg ZL; Seslar SP; Tuck SA; Tsuchida H; Naumova AV; Dupras SK; Lyu MS; Lee J; Hailey DW; Reinecke H; Pabon L; Fryer BH; MacLellan WR; Thies RS; Murry CE
    Nat Biotechnol; 2018 Aug; 36(7):597-605. PubMed ID: 29969440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive, multiscale framework for evaluation of arrhythmias arising from cell therapy in the whole post-myocardial infarcted heart.
    Yu JK; Franceschi W; Huang Q; Pashakhanloo F; Boyle PM; Trayanova NA
    Sci Rep; 2019 Jun; 9(1):9238. PubMed ID: 31239508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engraftment of human embryonic stem cell derived cardiomyocytes improves conduction in an arrhythmogenic in vitro model.
    Thompson SA; Burridge PW; Lipke EA; Shamblott M; Zambidis ET; Tung L
    J Mol Cell Cardiol; 2012 Jul; 53(1):15-23. PubMed ID: 22713758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expandable human cardiovascular progenitors from stem cells for regenerating mouse heart after myocardial infarction.
    Schwach V; Gomes Fernandes M; Maas S; Gerhardt S; Tsonaka R; van der Weerd L; Passier R; Mummery CL; Birket MJ; Salvatori DCF
    Cardiovasc Res; 2020 Mar; 116(3):545-553. PubMed ID: 31287499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes Promoted by Mechanical Stretch.
    Gu X; Zhou F; Mu J
    Med Sci Monit; 2021 Aug; 27():e931063. PubMed ID: 34381009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymosin β4 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell-derived cardiomyocytes in a porcine model of acute myocardial infarction.
    Tan SH; Loo SJ; Gao Y; Tao ZH; Su LP; Wang CX; Zhang SL; Mu YH; Cui YH; Abdurrachim D; Wang WH; Lalic J; Lim KC; Bu J; Tan RS; Lee TH; Zhang J; Ye L
    Theranostics; 2021; 11(16):7879-7895. PubMed ID: 34335970
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiac regeneration using pluripotent stem cells--progression to large animal models.
    Chong JJ; Murry CE
    Stem Cell Res; 2014 Nov; 13(3 Pt B):654-65. PubMed ID: 25087896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-mediated maturation of human pluripotent stem cell-derived cardiomyocytes: Towards a better model for cardiotoxicity?
    White MC; Pang L; Yang X
    Food Chem Toxicol; 2016 Dec; 98(Pt A):17-24. PubMed ID: 27265266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative transcriptional signatures for evaluating the maturity degree of pluripotent stem cell-derived cardiomyocytes.
    Chen R; He J; Wang Y; Guo Y; Zhang J; Peng L; Wang D; Lin Q; Zhang J; Guo Z; Li L
    Stem Cell Res Ther; 2019 Mar; 10(1):113. PubMed ID: 30925936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robust Cardiac Regeneration: Fulfilling the Promise of Cardiac Cell Therapy.
    Selvakumar D; Clayton ZE; Chong JJH
    Clin Ther; 2020 Oct; 42(10):1857-1879. PubMed ID: 32943195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.